Physician profile
John T Fox
NPI 1861476954
$6,760.16
in general payments reported to CMS, 2019-2025
32 companies · $924 in 2025
The $924 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $253 · 2021: $1,293 · 2022: $1,286 · 2023: $1,779 · 2024: $375 · 2025: $924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,077.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,770.21 | 2019-2025 | Dragonfly Opstar, Diamondback Coronary, Xience Skypoint |
| Endologix LLC | $856.85 | 2021 | |
| Janssen Pharmaceuticals, INC | $426.90 | 2021-2024 | Xarelto |
| Medtronic Vascular, INC. | $406.70 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $333.68 | 2021-2023 | Camzyos, Eliquis |
| Pfizer INC. | $313.61 | 2021-2024 | |
| Philips North America LLC | $302.54 | 2022-2025 | Igt Devices Undivided, Coronary Other |
| Shockwave Medical, INC | $275.13 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $258.29 | 2019-2025 | Impella |
| Bard Peripheral Vascular, INC. | $215.59 | 2023-2025 | Lutonix Drug Coated Balloon, Venovo, Atlas |
| Boston Scientific Corporation | $202.28 | 2020-2023 | Interlock |
| Bracco Diagnostics INC. | $191.81 | 2024 | |
| Novartis Pharmaceuticals Corporation | $180.69 | 2020-2023 | |
| Medtronic, INC. | $165.15 | 2023 | Corevalve Evolut R |
| Merck Sharp & Dohme LLC | $156.64 | 2023-2025 | Verquvo, Belsomra |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $110.42 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $102.58 | 2022-2025 | Farxiga, Wainua |
| Procyrion, INC. | $56.65 | 2024-2025 | Aortix System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.37 | 2020 | |
| Esperion Therapeutics, INC. | $44.88 | 2021 | |
| Cardiovascular Systems INC. | $43.32 | 2020 | |
| Kestra Medical Technology Services, INC. | $40.23 | 2025 | Assure Wcd |
| Penumbra, INC. | $38.17 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $35.64 | 2023 | Arcalyst |
| Masimo Corporation | $35.02 | 2024 | Set and Rainbow Set |
| Kiniksa Pharmaceuticals International, Plc | $33.26 | 2024 | Arcalyst |
| Terumo Medical Corporation | $32.16 | 2024 | Glidesheath Slender |
| Biotronik INC. | $25.53 | 2020 | |
| Ge Healthcare | $16.52 | 2021 | |
| Amgen INC. | $16.33 | 2022 | |
| Chiesi USA, INC. | $14.86 | 2023 | Kengreal |
| Lantheus Medical Imaging, INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.